TEHRAN – A scientific symposium on preclinical research into multiple sclerosis (MS), jointly organized by Royan Institute and the Multiple Sclerosis Research Center of Sina Hospital, affiliated with Tehran University of Medical Sciences, is scheduled to take place in Tehran on December 31.
The event, titled “Preclinical Studies of Multiple Sclerosis,” will bring together clinicians and researchers to discuss emerging experimental models, methodological advances, and translational research strategies aimed at improving the understanding and treatment of the disease.
The symposium will be held at the Multiple Sclerosis Research Center of Sina Hospital to mark the anniversary of the passing of Dr. Saeed Kazemi Ashtiani, the late founder of Royan Institute. It also seeks to honor his scientific legacy by fostering academic exchange and strengthening collaboration among researchers and clinicians.
Dr. Mohammad Javan of Royan Institute and Tarbiat Modares University, and Dr. Sajjad Sahabnegah of the Multiple Sclerosis Research Center of Sina Hospital, will serve as the scientific chairs. Dr. Alireza Alizadeh Moghadam Masouleh of Royan Institute will act as course director and executive secretary.
Preclinical studies are a key stage in developing drugs and therapeutic interventions. Conducted before human clinical trials, they help assess the efficacy and safety of potential treatments and the reproducibility of research findings.